Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric liquid mercaptopurine formulation bioequivalence study in childhood leukemia
NL-OMON20904Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mercaptopurine in acute lymphoblastic leukemia (ALL) and leukemia (2 arms), sponsored by Erasmus MC. Primary endpoints: Bioequivalence, Hematological toxicity and 1 more. Started May 2009; status: active, not recruiting.
02
Drugs
mercaptopurine
03
Conditions
acute lymphoblastic leukemia (ALL)leukemia
Beyond the preview
Go deeper on NL-OMON20904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20904.